SBP solbec pharmaceuticals limited

letter to shareholders, page-9

  1. 5,993 Posts.
    lightbulb Created with Sketch. 162
    re: ann - sbp002 drug kills tumours positively act I would say there are many biotechs looking at Solbecs technology . Dont forget the immune response kicks in on top of the 60% response rates from Nagourneys tests . There is not a drug in developement in Australia that comes even close to this . I would like to be a fly on the wall at BIO2004 to see who Steve Carter is talking to .
    Bruce Robinson has done a great job . It pays to work with the worlds best .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.